Observational studyMedical care2021
Markers of Quality Care for Newly Diagnosed People With Epilepsy on Medicaid.
Observational study in Medical care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Pooled it
- Article
- Antiseizure Medication Prescription Patterns for Treatment of Post-Traumatic Epilepsy.Neurology. Clinical practice · 2025Article
- Achieving epilepsy care for all: Ecosystem-based transformation.Epilepsia · 2025Review
- Clinician and patient readiness to engage with community health workers at epilepsy care centers.Frontiers in neurology · 2025Article
- A qualitative analysis of clinician perspectives on community health worker integration at epilepsy centers.Frontiers in neurology · 2025Article
- Innovating the practice of epilepsy care to improve patient outcomes: a model for community health worker integration.Frontiers in neurology · 2025Article
- Shining a Light: Advancing Health Equity in Overlooked Epilepsy Communities.Epilepsy currents · 2024Article
- Disparities in seizure outcomes revealed by large language models.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Characterizing emergency department and inpatient health care utilization after seizure-related hospitalization: A retrospective cohort study.Epilepsia · 2024Article
- Review
- Disparities in adherence and emergency department utilization among people with epilepsy: A machine learning approach.Seizure · 2023Article
- Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities.Neurology. Clinical practice · 2023Article
- Factors Associated With Quality Care Among Adults With Rheumatoid Arthritis.JAMA network open · 2022Article
- A framework for health equity in people living with epilepsy.Epilepsy research · 2022Review
- Drivers of US health care spending for persons with seizures and/or epilepsies, 2010-2018.Epilepsia · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundFor newly diagnosed people with epilepsy (PWE), proper treatment is important to improve outcomes, yet limited data exist on markers of quality care.
objectiveExamine markers of quality care for newly diagnosed PWE.
methodsUsing Medicaid claims data (2010-2014) for 15 states we identified adults 18-64 years of age diagnosed with incident epilepsy in 2012 or 2013. We built 5 sequential logistic regression models to evaluate: (1) seeing a neurologist; (2) diagnostic evaluation; (3) antiepileptic medication adherence; (4) serum drug levels checked; and (5) being in the top quartile of number of negative health events (NHEs). We adjusted for demographics, comorbidities, county-level factors, and the outcomes from all prior models.
resultsOf 25,663 PWE, 37.3% saw a neurologist, with decreased odds for those of older age, those residing in counties with low-density of neurologists, and certain race/ethnicities; about 57% of PWE received at least 1 diagnostic test; and nearly 62% of PWE were adherent to their medication. The most common comorbidities were hypertension (37.1%) and psychoses (26.9%). PWE with comorbidities had higher odds of seeing a neurologist and to have NHEs. Substance use disorders were negatively associated with medication adherence and positively associated with high NHEs.
conclusionsThere are notable differences in demographics among people with incident epilepsy who do or do not see a neurologist. Differences in NHEs persist, even after controlling for neurologist care and diagnostic evaluation. Continued attention to these disparities and comorbidities is needed in the evaluation of newly diagnosed PWE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.